Medicine:DTaP-IPV vaccine
 DPT-IPV vaccine in Japan | |
| Combination of | |
|---|---|
| DTaP vaccine | Vaccine |
| Inactivated poliovirus vaccine | Vaccine |
| Clinical data | |
| Trade names | Kinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others |
| Other names | diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content) |
| AHFS/Drugs.com | Kinrix Quadracel |
| Pregnancy category |
|
| Routes of administration | Intramuscular injection |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (IPV).[1][2]
It is also known as DTaP/IPV, dTaP/IPV, DTPa-IPV, or DPT-IPV.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.[1]
Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline[3] and Quadracel from Sanofi Pasteur.[4]
Repevax is available in the UK.[5][6]
Within Japan, the formulation is called 四種混合(shishukongou - "mixture of 4"). Astellas markets it under the クアトロバック ('Quattro-back') formulation, while another is available from Mitsubishi Tanabe Pharma named テトラビック ('Tetrabic').[7][8] A previous product by Takeda Pharmaceutical Company has been withdrawn by the company.[9]
References
- ↑ 1.0 1.1 1.2 "Diphtheria, Tetanus, Pertussis (Acellular, Component) And Poliomyelitis (Inactivated) Vaccine (Adsorbed)". Drugs.com. https://www.drugs.com/international/diphtheria-tetanus-pertussis-acellular-component-and-poliomyelitis-inactivated-vaccine-adsorbed.html.
- ↑ "DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination". Paediatric Drugs 21 (5): 397–408. October 2019. doi:10.1007/s40272-019-00353-7. PMID 31444785.
- ↑ "Kinrix". US Food and Drug Administration. https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172495.htm.
- ↑ "Quadracel". US Food and Drug Administration. https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm439856.htm.
- ↑ "Repevax, suspension for injection, in pre-filled syringe - Summary of Product Characteristics (SmPC) - (emc)". https://www.medicines.org.uk/emc/product/5580#gref.
- ↑ "14. Vaccines". British National Formulary (BNF) (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 1381. ISBN 978-0-85711-369-6.
- ↑ "医療用医薬品 : テトラビック (テトラビック皮下注シリンジ)". https://www.kegg.jp/medicus-bin/japic_med?japic_code=00060717.
- ↑ "医療用医薬品 : クアトロバック (クアトロバック皮下注シリンジ)". https://www.kegg.jp/medicus-bin/japic_med?japic_code=00060732.
- ↑ "【武田薬品】４種混合ワクチンの開発中止‐ノロウイルスなどに資源投入｜薬事日報ウェブサイト". 9 February 2015. https://www.yakuji.co.jp/entry41529.html.
 |  |
